Physician profile
Thomas Farrell Calton
NPI 1770515264
$3,507,051.37
in general payments reported to CMS, 2019-2025
16 companies · $535K in 2025
The $535K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480K · 2020: $448K · 2021: $442K · 2022: $473K · 2023: $549K · 2024: $579K · 2025: $535K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.7M · Travel and Lodging: $5,124 · Food and Beverage: $1,627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,656,417.10 |
| Travel and Lodging | $5,124.04 |
| Food and Beverage | $1,627.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Development Corporation | $3,493,833.57 | 2019-2025 | |
| Stryker Corporation | $8,004.15 | 2019-2024 | Mako, Triathlon, 1788 |
| Zimmer Biomet Holdings, INC. | $2,101.55 | 2021-2024 | Totalshield |
| Depuy Synthes Sales INC. | $1,124.74 | 2023-2024 | Actis |
| Think Surgical, INC. | $624.96 | 2022-2024 | |
| Encore Medical, Lp | $489.09 | 2023 | Djo Surgical |
| Radius Health, INC. | $362.31 | 2020-2021 | |
| Medtronic, INC. | $98.20 | 2022 | |
| Medtronic USA, INC. | $81.77 | 2019-2020 | |
| Ethicon US, LLC | $73.76 | 2021-2024 | Dermabond, Surgicel Nu-Knit |
| Uoc USA INC | $63.32 | 2023 | U2, Conformity, U-Motion II and Ustar II |
| Medical Device Business Services, INC. | $61.11 | 2024 | Attune |
| Ferring Pharmaceuticals INC. | $39.87 | 2020-2024 | Euflexxa |
| Pacira Therapeutics, INC. | $38.02 | 2020-2021 | |
| Heron Therapeutics, INC. | $36.54 | 2021-2023 | Zynrelef |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $18.41 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Calton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.